Schizophrenia: open trials in Serbia

9 open trials have a site in Serbia. Registry data; only the trial team decides who can take part.

NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Trial Treatment · Phase 3 · Intra-Cellular Therapies, Inc.
Clinic of Neurology and Psychiatry for Children and Youth, Belgrade · Institute of Mental Health Serbia, Belgrade · University Clinical Center NIS, Niš · Clinical Center of Vojvodina, Novi Sad
Registry updated 2026-11-03
NCT06540833
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Trial Treatment · Phase 2 · Intra-Cellular Therapies, Inc.
Clinical Center Dr Dragisa Misovic Dedinje, Belgrade · Special Hospital for Psychiatric Diseases Kovin, Kovin · University Clinical Center Kragujevac, Kragujevac · University Clinical Center NIS, Niš · Special Hospital for Psychiatric Diseases Sveti Vracevi, Novi Kneževac
Registry updated 2026-11-03
NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
University Clinical Center of Serbia - Dr Subotica 6 - PPDS, Belgrade · Military Medical Academy, Belgrade · Clinical Hospital Center Dragisa Misovic Dedinje, Belgrade · Gornja Toponica · Kovin · University Clinical Center Kragujevac, Kragujevac · Clinical Centre of Vojvodina, Novi Sad
Registry updated 2026-10-27
NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Kragujevac
Registry updated 2026-09-30
NCT07105098
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Trial Treatment · Phase 3 · Neurocrine Biosciences
Belgrade · Gornja Toponica · Kragujevac
Registry updated 2026-09-25
NCT07114874
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Trial Treatment · Phase 3 · Neurocrine Biosciences
Belgrade · Gornja Toponica · Kragujevac
Registry updated 2026-09-25
NCT07227818
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Trial Treatment · Phase 3 · Neurocrine Biosciences
Gornja Toponica · Kragujevac
Registry updated 2026-09-25
NCT05656469
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Trial Treatment · Phase 4 · Parnassia Groep
University of Belgrade, Faculty of Pharmacy, Belgrade
Registry updated 2026-06-02
NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
Trial Treatment · Phase 3 · Gedeon Richter Plc.
Institute for Mental Health, Belgrade · Clinic.Neuro.Psych.Child.Youth, Belgrade · Clinic for psychiatry, KCV, Novi Sad
Registry updated 2025-10-08

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error